HHS Deputy Secretary pick Jim O’Neill, believes the FDA should only consider safety and not efficacy when making approval decisions.
Someone should let him know that taking ineffective medical products DOES affect patient safety.
https://thehill.com/homenews/administration/5011492-jim-oneill-selected-to-lead-hhs-alongside-rfk-jr-as-deputy/
Someone should let him know that taking ineffective medical products DOES affect patient safety.
https://thehill.com/homenews/administration/5011492-jim-oneill-selected-to-lead-hhs-alongside-rfk-jr-as-deputy/
Comments
“We should reform FDA so that it’s approving drugs after their sponsors have demonstrated safety and let people start using them at their own risk , but not much risk of safety, But let’s prove efficacy after they’ve been legalized.”